Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""08044643"" wg kryterium: ISSN


Tytuł :
Safety of GH after treatment for childhood cancer.
Autorzy :
van Santen HM; Pediatric Endocrinology, Princess Màxima Center for Pediatric Oncology and Wilhelmina Children's Hospital, Utrecht, the Netherlands.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Dec; Vol. 183 (6), pp. C15-C18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cancer Survivors*
Human Growth Hormone/*administration & dosage
Human Growth Hormone/*adverse effects
Neoplasm Recurrence, Local/*chemically induced
Neoplasms/*drug therapy
Child ; Humans ; Neoplasm Recurrence, Local/diagnosis ; Neoplasms/diagnosis
Czasopismo naukowe
Tytuł :
Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 insensitivity.
Autorzy :
Cottrell E; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Cabrera CP; Centre for Translational Bioinformatics, Queen Mary University of London, London, UK.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ishida M; University College London, Great Ormond Street Institute of Child Health, London, UK.
Chatterjee S; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Greening J; University Hospitals of Leicester NHS Trust, Leicester, UK.
Wright N; The University of Sheffield Faculty of Medicine, Dentistry and Health, Sheffield, UK.
Bossowski A; Department of Pediatrics, Endocrinology and Diabetes with a Cardiology Unit, Medical University of Bialystok, Bialystok, Poland.
Dunkel L; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Deeb A; Paediatric Endocrinology Department, Mafraq Hospital, Abu Dhabi, United Arab Emirates.
Basiri IA; Mubarak Al-kabeer Hospital, Jabriya, Kuwait.
Rose SJ; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Mason A; Royal Hospital for Children, Glasgow, UK.
Bint S; Viapath, Guy's Hospital, London, UK.
Ahn JW; Addenbrookes Hospital, Cambridge, UK.
Hwa V; Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Metherell LA; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Moore GE; University College London, Great Ormond Street Institute of Child Health, London, UK.
Storr HL; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Dec; Vol. 183 (6), pp. 581-595.
Typ publikacji :
Journal Article
MeSH Terms :
DNA Copy Number Variations/*genetics
Genetic Testing/*methods
Human Growth Hormone/*genetics
Insulin-Like Growth Factor I/*genetics
Adolescent ; Child ; Child, Preschool ; Cohort Studies ; Female ; Human Growth Hormone/blood ; Humans ; Infant ; Insulin-Like Growth Factor I/metabolism ; Male
Czasopismo naukowe
Tytuł :
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response.
Autorzy :
Chiloiro S; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Giampietro A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Mirra F; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Donfrancesco F; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Tartaglione T; Department of Radiology, Istituto Dermatopatico dell'Immacolata, IRCCS, Rome, Italy.; Istituto di Radiologica, Università Cattolica del Sacro Cuore, Rome, Italy.
Mattogno PP; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Angelini F; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Liverana L; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Gessi M; Department di Pathology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Carmelo A; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Rindi G; Department di Pathology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Istitute of Pathology, Università Cattolica del Sacro Cuore, Rome, Italy.
Giustina A; Endocrinology Vita-Salute San Raffaele University, IRCCS, San Raffaele Hospital, Milano, Italy.
Fleseriu M; Departments of Medicine (Endocrinology) and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA.
Pontecorvi A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
De Marinis L; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Bianchi A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2021 Feb; Vol. 184 (2), pp. 217-229.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Somatostatin/*analogs & derivatives
Acromegaly/metabolism ; Acromegaly/pathology ; Adenoma/drug therapy ; Adenoma/metabolism ; Adenoma/pathology ; Adolescent ; Adult ; Aged ; Chemotherapy, Adjuvant ; Cross-Sectional Studies ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Growth Hormone-Secreting Pituitary Adenoma/drug therapy ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Human Growth Hormone/administration & dosage ; Humans ; Insulin-Like Growth Factor I/analysis ; Insulin-Like Growth Factor I/metabolism ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Somatostatin/administration & dosage ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues.
Autorzy :
Giavoli C; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Profka E; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Giancola N; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Rodari G; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Giacchetti F; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Ferrante E; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Arosio M; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Mantovani G; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Oct; Vol. 183 (4), pp. L13-L15.
Typ publikacji :
Letter
MeSH Terms :
Hormone Replacement Therapy*
Growth Hormone/*deficiency
Human Growth Hormone/*therapeutic use
Hypopituitarism/*drug therapy
Medication Adherence/*statistics & numerical data
Adolescent ; Adult ; Aged ; Betacoronavirus ; COVID-19 ; Child ; Child, Preschool ; Coronavirus Infections/epidemiology ; Female ; Human Growth Hormone/supply & distribution ; Humans ; Infant ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Young Adult
Opinia redakcyjna
Tytuł :
Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Autorzy :
Thomas-Teinturier C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatric Endocrinology, AP-HP, Université Paris Saclay, site Bicetre, Le Kremlin Bicêtre, France.
Oliver-Petit I; Department of Pediatric Endocrinology, Children Hospital, Toulouse, France.
Pacquement H; Department of Pediatrics Oncology, Institut Curie, Paris, France.
Fresneau B; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatrics Oncology, Institut Gustave Roussy, Villejuif, France.
Allodji RS; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Veres C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Bolle S; Department of Radiotherapy Oncology, Institut Gustave Roussy, Villejuif, France.
Berchery D; Centre Claudius Régaud, Toulouse, France.
Demoor-Goldschmidt C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatrics Oncology, CHU Angers, Angers, France.
Haddy N; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Diallo I; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
de Vathaire F; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Oct; Vol. 183 (4), pp. 471-480.
Typ publikacji :
Journal Article
MeSH Terms :
Cancer Survivors/*statistics & numerical data
Human Growth Hormone/*therapeutic use
Neoplasms, Second Primary/*epidemiology
Adolescent ; Adult ; Aged ; Brain Neoplasms/chemically induced ; Brain Neoplasms/epidemiology ; Case-Control Studies ; Child ; Child, Preschool ; Cohort Studies ; Cranial Irradiation/adverse effects ; Female ; Follow-Up Studies ; France/epidemiology ; Hormone Replacement Therapy/adverse effects ; Hormone Replacement Therapy/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Male ; Meningeal Neoplasms/chemically induced ; Meningeal Neoplasms/epidemiology ; Meningioma/chemically induced ; Meningioma/epidemiology ; Middle Aged ; Neoplasms, Second Primary/chemically induced ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Growth hormone retesting during puberty: a cohort study.
Autorzy :
Cavarzere P; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.
Gaudino R; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Sandri M; Data Methods and Systems Statistical Laboratory, University of Brescia, Brescia, Italy.
Ramaroli DA; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.
Pietrobelli A; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Zaffanello M; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Guzzo A; Laboratory Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Salvagno GL; Laboratory Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Piacentini G; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Antoniazzi F; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.; Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Jun 01; Vol. 182 (6), pp. 559-567.
Typ publikacji :
Journal Article
MeSH Terms :
Human Growth Hormone/*deficiency
Puberty/*metabolism
Child ; Female ; Humans ; Insulin-Like Growth Factor I/analysis ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Growth hormone treatments and cognitive functioning in children with Prader-Willi syndrome.
Autorzy :
Deal CL; Endocrine and Diabetes Service, CHU-Ste-Justine, Sainte-Justine Hospital, Montreal, Quebec, Canada.
Rogol AD; University of Virginia, Charlottesville, Virginia, USA.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Jun; Vol. 182 (6), pp. C21-C25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cognition/*drug effects
Human Growth Hormone/*therapeutic use
Prader-Willi Syndrome/*drug therapy
Prader-Willi Syndrome/*psychology
Child ; Child, Preschool ; Humans ; Recombinant Proteins/therapeutic use
Czasopismo naukowe
Tytuł :
Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly.
Autorzy :
van der Lely AJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Kuhn E; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.
Muhammad A; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Coopmans EC; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Neggers SJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Chanson P; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Le Kremlin-Bicêtre, France.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Jun; Vol. 182 (6), pp. D17-D29.
Typ publikacji :
Journal Article
MeSH Terms :
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Receptors, Somatotropin/*therapeutic use
Human Growth Hormone/antagonists & inhibitors ; Human Growth Hormone/therapeutic use ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly?
Autorzy :
Lenders NF; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.
McCormack AI; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.
Ho KKY; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 May; Vol. 182 (5), pp. R67-R82.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Age Factors ; Disease Management ; Dose-Response Relationship, Drug ; Female ; Human Growth Hormone/administration & dosage ; Human Growth Hormone/therapeutic use ; Humans ; Male ; Quality of Life ; Sex Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
Autorzy :
Donze SH; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.
Damen L; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.
Mahabier EF; Dutch Growth Research Foundation, Rotterdam, The Netherlands.
Hokken-Koelega ACS; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Apr; Vol. 182 (4), pp. 405-411.
Typ publikacji :
Journal Article
MeSH Terms :
Cognitive Dysfunction/*drug therapy
Human Growth Hormone/*therapeutic use
Prader-Willi Syndrome/*drug therapy
Prader-Willi Syndrome/*psychology
Adolescent ; Age Factors ; Child ; Child, Preschool ; Cognition/drug effects ; Cohort Studies ; Female ; Genotype ; Human Growth Hormone/administration & dosage ; Humans ; Infant ; Longitudinal Studies ; Male ; Netherlands ; Prader-Willi Syndrome/genetics ; Prospective Studies ; Treatment Outcome ; Wechsler Scales
Czasopismo naukowe
Tytuł :
All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis.
Autorzy :
Tritos NA; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Mattsson AF; Pfizer Endocrine Care, Pfizer Health AB, Sollentuna, Sweden.
Vila G; Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Biller BMK; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Klibanski A; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Valluri S; Global Biometrics and Data Management, Pfizer Inc, New York, New York, USA.
Hey-Hadavi J; Pfizer Endocrine Care, Inc, New York, New York, USA.
Kelepouris N; Pfizer Endocrine Care, Inc, New York, New York, USA.
Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2020 Mar; Vol. 182 (3), pp. 285-292.
Typ publikacji :
Journal Article
MeSH Terms :
Mortality*
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Receptors, Somatotropin/*antagonists & inhibitors
Acromegaly/metabolism ; Adult ; Age Factors ; Aged ; Cause of Death ; Cohort Studies ; Female ; Human Growth Hormone/therapeutic use ; Humans ; Insulin-Like Growth Factor I/metabolism ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Time Factors ; Time-to-Treatment
Czasopismo naukowe
Tytuł :
Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
Autorzy :
Bolfi F; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.
Neves AF; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.
Boguszewski CL; Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil.
Nunes-Nogueira VS; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Nov; Vol. 181 (5), pp. L5-L6.
Typ publikacji :
Letter; Meta-Analysis; Systematic Review
MeSH Terms :
Acromegaly/*blood
Acromegaly/*mortality
Human Growth Hormone/*blood
Humans ; Mortality/trends
Raport
Tytuł :
Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Autorzy :
Monaghan PJ; Department of Clinical Biochemistry, The Christie Pathology Partnership, The Christie NHS Foundation Trust; University of Manchester, Faculty of Medical and Human Sciences, Institute of Inflammation and Repair, Manchester, UK.
Trainer PJ; Department of Endocrinology, The Christie NHS Foundation Trust; University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Nov; Vol. 181 (5), pp. C17-C20.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Acromegaly/*blood
Acromegaly/*diagnosis
Glucose Tolerance Test/*methods
Human Growth Hormone/*blood
Adult ; Glucose Tolerance Test/standards ; Humans
Czasopismo naukowe
Tytuł :
Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.
Autorzy :
Daskas N; Department of Paediatric Endocrinology, University Hospitals Bristol, Bristol, UK.
Sharples P; Department of Paediatric Neurology, University Hospitals Bristol, Bristol, UK.
Likeman M; School of Clinical Sciences, University of Bristol, Bristol, UK.
Lightman S; Department of Radiology, University Hospitals Bristol, Bristol, UK.
Crowne EC; Department of Paediatric Endocrinology, University Hospitals Bristol, Bristol, UK.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Sep; Vol. 181 (3), pp. 331-338.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Injuries, Traumatic/*blood
Brain Injuries, Traumatic/*psychology
Fatigue/*blood
Fatigue/*psychology
Human Growth Hormone/*blood
Quality of Life/*psychology
Adolescent ; Adult ; Brain Injuries, Traumatic/epidemiology ; Child ; Depression/blood ; Depression/epidemiology ; Depression/psychology ; Fatigue/epidemiology ; Female ; Humans ; Male ; Young Adult
Czasopismo naukowe
Tytuł :
MANAGEMENT OF ENDOCRINE DISEASE: Individualised management of acromegaly.
Autorzy :
Bollerslev J; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Heck A; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Olarescu NC; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Aug; Vol. 181 (2), pp. R57-R71.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Management*
Acromegaly/*blood
Acromegaly/*therapy
Human Growth Hormone/*blood
Precision Medicine/*methods
Acromegaly/diagnosis ; Combined Modality Therapy/methods ; Combined Modality Therapy/trends ; Humans ; Precision Medicine/trends
Czasopismo naukowe
Tytuł :
MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment.
Autorzy :
Mazziotti G; Department of Biomedical Sciences, Humanitas University.; Endocrine, Diabetes and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Lania AGA; Department of Biomedical Sciences, Humanitas University.; Endocrine, Diabetes and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Canalis E; Departments of Orthopaedic Surgery and Medicine, The UConn Musculoskeletal Institute, UConn Health, Farmington, Connecticut, USA.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Aug; Vol. 181 (2), pp. R45-R56.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Management*
Acromegaly/*blood
Acromegaly/*therapy
Human Growth Hormone/*blood
Acromegaly/diagnostic imaging ; Bone Density/physiology ; Bone Diseases/blood ; Bone Diseases/diagnostic imaging ; Bone Diseases/therapy ; Bone Remodeling/physiology ; Fractures, Bone/blood ; Fractures, Bone/diagnostic imaging ; Fractures, Bone/prevention & control ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Autorzy :
Schilbach K; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Gar C; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Lechner A; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Nicolay SS; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Schwerdt L; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Haenelt M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Dal J; Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Jørgensen JL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Störmann S; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Schopohl J; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Bidlingmaier M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Jul; Vol. 181 (1), pp. 55-67.
Typ publikacji :
Evaluation Study; Journal Article; Multicenter Study
MeSH Terms :
Glucose Tolerance Test*
Acromegaly/*diagnosis
Human Growth Hormone/*analysis
Immunoassay/*methods
Adult ; Aged ; Female ; Humans ; Male ; Menstrual Cycle/blood ; Middle Aged ; Prospective Studies ; Reference Values ; Retrospective Studies ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart.
Autorzy :
Ziagaki A; Interdisciplinary Centre of Metabolism, Endocrinology, Diabetes and Metabolism.
Blaschke D; Clinic of Cardiology, Charité - University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Haverkamp W; Clinic of Cardiology, Charité - University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Plöckinger U; Interdisciplinary Centre of Metabolism, Endocrinology, Diabetes and Metabolism.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2019 Jul; Vol. 181 (1), pp. 79-91.
Typ publikacji :
Journal Article
MeSH Terms :
Time Factors*
Growth Hormone/*administration & dosage
Heart Failure/*etiology
Hormone Replacement Therapy/*methods
Human Growth Hormone/*deficiency
Adult ; Drug Administration Schedule ; Echocardiography ; Female ; Follow-Up Studies ; Heart/drug effects ; Humans ; Insulin-Like Growth Factor I/drug effects ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY.
Autorzy :
Buchfelder M; Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany.
van der Lely AJ; Department of Medicine, Erasmus University MC, Rotterdam, the Netherlands.
Biller BMK; Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Webb SM; Endocrinologia (Malalties de la Hipòfisi), Hospital Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Brue T; Department of Endocrinology, Centre de Référence des Maladies Rares d'Origine Hypophysaire, Hôpital de la Conception, Marseille, France.
Strasburger CJ; Department of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Campus Mitte, Berlin, Germany.
Ghigo E; University Hospital Città Salute e Scienza, Turin, Italy.
Camacho-Hubner C; Endocrine Care Global Medical Affairs, Pfizer Inc., New York City, New York, USA.
Pan K; Endocrine Care Global Clinical Affairs, Pfizer Inc., Collegeville, Pennsylvania, USA.
Lavenberg J; Endocrine Care Global Clinical Affairs, Pfizer Inc., Collegeville, Pennsylvania, USA.
Jönsson P; Endocrine Care, Pfizer Health AB, Sollentuna, Sweden.
Hey-Hadavi JH; Endocrine Care Global Medical Affairs, Pfizer Inc., New York City, New York, USA.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2018 Dec 01; Vol. 179 (6), pp. 419-427.
Typ publikacji :
Journal Article; Pragmatic Clinical Trial
MeSH Terms :
Internationality*
Acromegaly/*diagnosis
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Human Growth Hormone/*metabolism
Acromegaly/epidemiology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Human Growth Hormone/administration & dosage ; Humans ; Infant ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study.
Autorzy :
Muhammad A; Endocrinology Section, Department of Medicine.
Coopmans EC; Endocrinology Section, Department of Medicine.
Delhanty PJD; Endocrinology Section, Department of Medicine.
Dallenga AHG; Department of Neurosurgery, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Haitsma IK; Department of Neurosurgery, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Janssen JAMJL; Endocrinology Section, Department of Medicine.
van der Lely AJ; Endocrinology Section, Department of Medicine.
Neggers SJCMM; Endocrinology Section, Department of Medicine.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2018 Oct 12; Vol. 179 (5), pp. 269-277. Date of Electronic Publication: 2018 Oct 12.
Typ publikacji :
Journal Article
MeSH Terms :
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Insulin-Like Growth Factor I/*metabolism
Somatostatin/*analogs & derivatives
Acromegaly/blood ; Drug Substitution ; Follow-Up Studies ; Glucose Tolerance Test ; Hormone Antagonists/therapeutic use ; Human Growth Hormone/therapeutic use ; Humans ; Insulin/blood ; Octreotide/therapeutic use ; Prospective Studies ; Somatostatin/adverse effects ; Somatostatin/therapeutic use ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies